Prescriva Review

Is Prescriva worth it?

Prescriva's whole pitch comes down to this: people who want compounded semaglutide or tirzepatide with the pharmacy names published up front. It runs $249/month — a premium versus the rest of the category, so its specific extras need to earn that difference. Its standout is a needle-free oral option, which very few providers offer.

Beyond the medication itself, Prescriva takes HSA/FSA payment.

How much Prescriva actually costs

Compounded semaglutide runs $249/month, compounded semaglutide runs $279/month, and compounded tirzepatide runs $339/month.

For context, the typical ongoing price across the GLP-1 providers we track is around $169/month. Prescriva's standing rate sits at the premium end of that range, well above the cheapest options in the category.

For a direct comparison, Wellorithm runs semaglutide and tirzepatide from $247/month — worth pricing against Prescriva before you commit.

Medications: what Prescriva prescribes

Prescriva prescribes semaglutide (the active drug in Wegovy and Ozempic) and tirzepatide (the active drug in Zepbound and Mounjaro) — the two molecules with the strongest published weight-loss trial outcomes. These are dispensed as compounded formulations from a licensed pharmacy, which is how the price stays below brand-name pens. Compounded drugs aren't FDA-approved as finished products — the standard trade-off across the compounded-GLP-1 market.

Prescriva's needle-free oral option is a real draw if you've been avoiding a GLP-1 because of injections. Just set expectations on the science: oral and buccal delivery of these peptides is far less studied than the injectable versions the trials used. Treat it as a convenience option, not a proven equal to the shot.

Who Prescriva is best for — and who should skip it

A good fit if you…

• are needle-averse and want a non-injectable option, since the oral route skips the weekly injection most GLP-1 programs require.

Look elsewhere if you…

• want the lowest total cost over 6–12 months — a flat-rate provider like Collective will likely beat the ongoing price.
• specifically want an FDA-approved brand-name pen instead of a compounded formulation — that's not what this provider fills.
• need to bill insurance, since like most of this market it's cash-pay with no claims filed on your behalf.

Trust, safety, and medical oversight

We found no FDA warning letter on file for it, though a clean record isn't the same as an endorsement — read the rest of this review for the full picture. As with any compounded program, the most important step you can take is confirming which licensed pharmacy fills your prescription and what's in the formulation — we explain how in our scoring methodology.

Bottom line

Prescriva costs more than the budget end of the market, so it makes the most sense if its specific extras — the oral option especially matter to you. If they don't, you can likely get the same medication for less elsewhere. If you're comparison-shopping, Direct Meds is one of the closest alternatives we track — worth a look before deciding.